You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/71706
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLabropoulos, Nicos-
dc.contributor.authorSpentzouris, Georgios-
dc.contributor.authorSobreira, Marcone Lima-
dc.date.accessioned2014-05-27T11:24:42Z-
dc.date.accessioned2016-10-25T18:28:41Z-
dc.date.available2014-05-27T11:24:42Z-
dc.date.available2016-10-25T18:28:41Z-
dc.date.issued2010-06-01-
dc.identifierhttp://dx.doi.org/10.1590/S1677-54492010000200010-
dc.identifier.citationJornal Vascular Brasileiro, v. 9, n. 2, p. 72-75, 2010.-
dc.identifier.issn1677-5449-
dc.identifier.urihttp://hdl.handle.net/11449/71706-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/71706-
dc.description.abstractRecurrent venous thromboembolism is a significant problem leading to increased morbidity and mortality. It has a high impact on patients' quality of life and imposes a great financial burden on society. Cumulative recurrence has been reported as 40% at 10 years, while the chance of developing postthrombotic signs and symptoms in the lower extremities almost quadruples when ipsilateral. There is also a higher chance of developing pulmonary hypertension. Important factors for recurrence are unprovoked episodes of deep vein thrombosis, malignancy and older age. The evidence for other factors is controversial. Accurate diagnosis and treatment tailored to the patients' history, thrombotic events and risk factors are necessary to optimize management and prevent recurrence.en
dc.format.extent72-75-
dc.language.isopor-
dc.sourceScopus-
dc.subjectAnticoagulation-
dc.subjectPostthrombotic syndrome-
dc.subjectPulmonary hypertension-
dc.subjectRecurrent venous thromboembolism-
dc.subjectanticoagulant agent-
dc.subjectantivitamin K-
dc.subjectheparin-
dc.subjectanticoagulant therapy-
dc.subjectblood clot lysis-
dc.subjectclinical classification-
dc.subjectcompression garment-
dc.subjectcomputer assisted tomography-
dc.subjectdeep vein thrombosis-
dc.subjectdiagnostic accuracy-
dc.subjectdiagnostic imaging-
dc.subjectdisease duration-
dc.subjectdisease severity-
dc.subjectechography-
dc.subjectfollow up-
dc.subjecthigh risk patient-
dc.subjecthuman-
dc.subjectlung embolism-
dc.subjectmedical history-
dc.subjectmortality-
dc.subjectnuclear magnetic resonance imaging-
dc.subjectpatient attitude-
dc.subjectpostthrombosis syndrome-
dc.subjectpulmonary hypertension-
dc.subjectquality of life-
dc.subjectrecurrent disease-
dc.subjectrisk assessment-
dc.subjectrisk factor-
dc.subjectrisk reduction-
dc.subjectsensitivity and specificity-
dc.subjectsurvival rate-
dc.subjectsymptomatology-
dc.subjectthrombosis prevention-
dc.subjecttreatment duration-
dc.subjecttreatment indication-
dc.titleSignificância clínica de tromboembolismo venoso recorrentept
dc.title.alternativeClinical significance of recurrent venous thromboembolismen
dc.typeoutro-
dc.contributor.institutionStony Brook University Medical Center-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationDivision of Vascular Surgery Stony Brook University Medical Center, Stony Brook, NY 11794-
dc.description.affiliationDepartment of Surgery Botucatu Medical School, Botucatu, SP-
dc.description.affiliationUnespDepartment of Surgery Botucatu Medical School, Botucatu, SP-
dc.identifier.doi10.1590/S1677-54492010000200010-
dc.identifier.scieloS1677-54492010000200010-
dc.rights.accessRightsAcesso aberto-
dc.identifier.file2-s2.0-77958122307.pdf-
dc.relation.ispartofJornal Vascular Brasileiro-
dc.identifier.scopus2-s2.0-77958122307-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.